Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1007/s11033-025-10485-4
Published Online: 2025-04-08
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shaw, Swetaleena
Porel, Pratyush
Aran, Khadga Raj https://orcid.org/0000-0002-2450-2975
Text and Data Mining valid from 2025-04-08
Version of Record valid from 2025-04-08
Article History
Received: 2 March 2025
Accepted: 31 March 2025
First Online: 8 April 2025
Declarations
:
: The authors declare no competing interests.
: Not applicable.